Alkermes
ALKS
#2752
Rank
A$8.70 B
Marketcap
A$52.24
Share price
-0.77%
Change (1 day)
7.24%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): A$0.36 Billion

According to Alkermes's latest financial reports the company's current earnings are A$1.56 Billion. In 2025 the company made an earning of A$0.42 Billion a decrease over its 2024 earnings that were of A$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.36 B-15.4%
2025 A$0.42 B-34.87%
2024 A$0.65 B-17.97%
2023 A$0.79 B-468.52%
2022 -A$0.22 Billion449.24%
2021 -A$39.46 Million-68.04%
2020 -A$0.13 Billion-52.1%
2019 -A$0.26 Billion64.49%
2018 -A$0.16 Billion-15.04%
2017 -A$0.19 Billion-34.2%
2016 -A$0.29 Billion-5.34%
2015 -A$0.3 Billion35084.97%
2014 -A$0.85 Million
2012 A$10.42 M-117.81%
2011 -A$58.56 Million-12.69%
2010 -A$67.07 Million94.3%
2009 -A$34.52 Million-117.7%
2008 A$0.19 B622.63%
2007 A$26.98 M
2004 -A$0.11 Billion-14.48%
2003 -A$0.13 Billion11.88%
2002 -A$0.12 Billion39.65%
2001 -A$79.88 Million5.73%
2000 -A$75.55 Million-28.91%
1999 -A$0.11 Billion237.28%
1998 -A$31.51 Million100.05%
1997 -A$15.75 Million-37.93%
1996 -A$25.38 Million82.72%
1995 -A$13.89 Million-26.79%
1994 -A$18.97 Million-72.78%
1993 -A$69.68 Million208.07%
1992 -A$22.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.49 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.17 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.87 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.75 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.48 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.59 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-A$0.3 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.39 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.19 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel